3 Indian Stocks Trading Below Cash Flow Value

With US Treasury yields sitting at multi month highs, the market cost of capital is front and centre again. Higher risk free rates can punish richly priced stocks and reward companies where cash flows already justify the share price. That is where the Undervalued Stocks Based On Cash Flows screener comes in. This article walks through three stocks that our SWS DCF model flags as potential value opportunities.

The three stocks highlighted next are only a small sample, as our full screen identifies 25 more companies where the SWS DCF model suggests cash flows already go a long way toward supporting current market prices. To identify, analyze, and prioritise those opportunities directly, head into the Undervalued Stocks Based On Cash Flows screener

Entero Healthcare Solutions (NSEI:ENTERO)

Entero Healthcare Solutions runs a large healthcare product distribution business in India, supplying medicines, medical devices and hospital consumables through importing, central warehousing and last mile delivery to pharmacies, hospitals and clinics. This creates recurring cash flows from B2B relationships that fit the screener’s cash flow driven value theme. The company reports all of its ₹71,278.88 million revenue from trading pharmaceutical and surgical products in India. Entero Healthcare Solutions currently has a market cap of about ₹61.3b.

Entero Healthcare Solutions may be worth a closer look if you want cash flow backed exposure to India’s healthcare sector. The company combines a wide distribution network, recurring B2B contracts and a focus on higher margin product categories. At the same time, reliance on acquisitions, modest net margins and competition from online health platforms mean execution quality and balance sheet discipline really matter. Governance changes and a relatively new management team add another layer to watch. The SWS DCF suggests the current share price sits below its estimated fair value, so the key question is whether Entero can convert that potential into sustainable cash flows before the market fully reflects it.

Entero Healthcare Solutions is building scale through acquisitions while running a recurring B2B distribution engine, yet the real story may be what the cash flow math already implies. Walk through the DCF valuation analysis for Entero Healthcare Solutions and see what the market may be missing.

Build your own cash flow backed shortlist

Entero Healthcare Solutions and the two other stocks in this article all came from a single Simply Wall St screen, but the real edge is building filters that fit your own process. Use our flexible Screener to mix valuation, growth, balance sheet and risk metrics, or start with any of our curated Investing Ideas.

M & B Engineering (NSEI:MBEL)

M & B Engineering designs, manufactures and installs pre engineered metal buildings, steel roofing and heavy structural steel for bridges, flyovers and power plant structures. This ties directly into the screener’s focus on contract based cash flows from multi year projects. The company generates all of its ₹13,131.688 million revenue from pre engineered buildings, structural steels, steel roofing and related components, serving sectors from warehousing to power and railways in India and overseas. M & B Engineering currently has a market cap of about ₹16.3b.

M & B Engineering catches the eye because its contract heavy steel projects give potential visibility on cash flows, yet the stock trades well below the SWS DCF estimate of fair value. Earnings growth forecasts and recent quarterly results point to rising profit potential, while a brownfield expansion in heavy structural steel could extend that cash flow story over time. The flip side is pressure on profit margins, a modest dividend that is not fully backed by free cash flow and a capital structure that leans on external borrowing, which raises funding risk if conditions tighten. For investors who can live with those trade offs, there may be more to this project pipeline than the current share price reflects.

M & B Engineering’s project pipeline and SWS DCF gap suggest that the share price may not yet fully reflect the story. See how the contract book, margins and funding risks intersect in the analysis report for M & B Engineering

Balrampur Chini Mills (NSEI:BALRAMCHIN)

Balrampur Chini Mills is one of India’s larger integrated sugar producers, with a business built around manufacturing and selling sugar while also monetising by products like molasses, ethanol and power from bagasse. Sugar operations are the main cash flow engine, generating about ₹55.6b of revenue, with a further ₹18.0b from the distillery segment and smaller contributions from polylactic acid and other products, which together help smooth cash inflows. The company has a market cap of roughly ₹138.0b.

Balrampur Chini Mills draws interest because the recurring cash flows from sugar and allied products underpin a DCF value that currently sits above the share price, even after a year where earnings declined and margins came under pressure. Supportive ethanol and sugar policies, efficiency gains in cane yields and a move into PLA bioplastics may strengthen cash generation over time. However, heavy debt funding for new projects and exposure to government decisions on pricing keep risk firmly on the table. For investors who are comfortable with that trade off, the mix of core sugar cash flows and an emerging green chemicals business suggests that the headline numbers do not tell the full story.

Balrampur Chini Mills has an integrated sugar and ethanol cash engine that some investors may still be pricing on headlines. The real question is what the analysis report for Balrampur Chini Mills reveals about one underappreciated swing factor

Seeking Fresh Alternatives Before They Fly

Some stocks are building quiet breakout momentum while the crowd looks elsewhere. Consider using that gap before the story is widely known. Prices move, information drops, and some investors choose to act earlier in the cycle.

• Target resilient income by scanning companies in the 434 dividend fortresses that focus on maintaining cash flows and payouts while prices may still be under the radar.
• Spot potential breakout trends with the curated 56 AI infrastructure stocks that focuses on businesses supplying the backbone for rising AI demand before broader attention and valuations develop.
• Track early power grid upgrades through the selective 39 power grid technology and infrastructure stocks that highlights companies aligned with long term electrification shifts while they may still be relatively thinly followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com